Prevalence of Undiagnosed D.M and Prediabetic Patients in Iraq

Asmaa Ameen Ghareeb; Hayder Ali Saeed; Fouad Kader Abdullah

doi:10.51699/17g9eh26

Authors

Asmaa Ameen Ghareeb B.Sc. in Medical Laboratory Techniques, Kirkuk Health Directorate, Kirkuk First Sector, Kirkuk, Iraq
Hayder Ali Saeed B.Sc. in Chemistry, Diyala Health Directorate, Baqubah Teaching Hospital, Diyala, Iraq
Fouad Kader Abdullah M.Sc. in Microbiology, Kirkuk Health Directorate, Kirkuk First Sector, Kirkuk, Iraq

DOI:

https://doi.org/10.51699/17g9eh26

Keywords:

Diabetes Mellitus, Prediabetes, HbA1c, BMI, RBS, Prevalence

Abstract

Undiagnosed diabetes mellitus (DM) and prediabetes are important public health issues. This study analyzed the prevalence among Iraqi adults and their association with age, sex, and BMI. This study included 100 adult participants from Kirkuk- Iraq. Their diabetes status was identified based on the results of HbA1c test as normal (<5.7%), prediabetes (5.7-6.4%), or diabetes which are above (6.5%). Data was analyzed using Kruskal-Wallis tests and multinomial logistic regression. Results is 69% of the participants were normal diabetic status HbA1c > 5.7%, while 25% had prediabetes and 6% had a diabetic range of HbA1c. BMI, RBS, HbA1c, and insulin was different significantly between groups. Regression analysis showed an association between prediabetes participants and RBS (OR=1.06, P=0.007). while insulin was associated with prediabetes (OR=1.47, p<0.001). Prediabetes and diabetic participants were present in the studies population, RBS and insulin showed a significant relation with diabetic status.

References

[1] A. C. Powers, K. D. Niswender, and C. Evans-Molina, “Diabetes mellitus: Diagnosis, classification, and pathophysiology,” Diabetes, vol. 1000, no. 415, pp. 3195–3204, 2022.

[2] H. Alkhalidy, Y. Wang, and D. Liu, “Dietary flavonoids in the prevention of T2D: An overview,” Nutrients, vol. 10, no. 4, p. 438, 2018.

[3] H. D. McIntyre et al., “Gestational diabetes mellitus,” Nature Reviews Disease Primers, vol. 5, no. 1, p. 47, 2019.

[4] N. Rachdaoui, “Insulin: The friend and the foe in the development of type 2 diabetes mellitus,” International Journal of Molecular Sciences, vol. 21, no. 5, p. 1770, 2020.

[5] M. Viigimaa et al., “Macrovascular complications of type 2 diabetes mellitus,” Current Vascular Pharmacology, vol. 18, no. 2, pp. 110–116, 2020.

[6] J. Tuomilehto et al., “Epidemiology of macrovascular disease and hypertension in diabetes mellitus,” in International Textbook of Diabetes Mellitus, 2015, pp. 1005–1030.

[7] G. Li et al., “Evaluation of ADA HbA1c criteria in the diagnosis of pre-diabetes and diabetes in a population of Chinese adolescents and young adults at high risk for diabetes: A cross-sectional study,” BMJ Open, vol. 8, no. 8, p. e020665, 2018.

[8] S. Pengpid and K. Peltzer, “Prevalence and factors associated with undiagnosed type 2 diabetes among adults in Iraq: Analysis of cross-sectional data from the 2015 STEPS survey,” BMJ Open, vol. 12, no. 11, p. e064293, 2022.

[9] M. Şahin and E. Aybek, “Jamovi: An easy to use statistical software for the social scientists,” International Journal of Assessment Tools in Education, vol. 6, no. 4, pp. 670–692, 2019.

[10] B. Rashad, N. R. Hussein, V. H. Dirbas, and I. A. Naqid, “Prevalence and determinants of undiagnosed diabetes mellitus among adults in Zakho City, Kurdistan Region, Iraq: A community-based cross-sectional study,” Cureus, vol. 17, no. 1, 2025.

[11] E. Fárková et al., “Weight loss in conservative treatment of obesity in women is associated with physical activity and circadian phenotype: A longitudinal observational study,” BioPsychoSocial Medicine, vol. 13, no. 1, p. 24, 2019.

[12] M. Blüher, “Obesity: Global epidemiology and pathogenesis,” Nature Reviews Endocrinology, vol. 15, no. 5, pp. 288–298, 2019.

[13] M. E. Bowen, L. Xuan, I. Lingvay, and E. A. Halm, “Performance of a random glucose case-finding strategy to detect undiagnosed diabetes,” American Journal of Preventive Medicine, vol. 52, no. 6, pp. 710–716, 2017.

[14] M. E. Bowen, L. Xuan, I. Lingvay, and E. A. Halm, “Random blood glucose: A robust risk factor for type 2 diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 4, pp. 1503–1510, 2015.

[15] K. Moravcová et al., “Comparing the efficacy of digital and in-person weight loss interventions for patients with obesity and glycemic disorders: Evidence from a randomized non-inferiority trial,” Nutrients, vol. 16, no. 10, p. 1510, 2024.

[16] G. Kaur et al., “Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis,” PLOS ONE, vol. 15, no. 11, p. e0242415, 2020.

[17] D. Care, “Care in diabetes—2022,” Diabetes Care, vol. 45, Suppl. 1, p. S17, 2022.

[18] K. Ogurtsova et al., “IDF Diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021,” Diabetes Research and Clinical Practice, vol. 183, p. 109118, 2022.